XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities at carrying and fair value
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
March 31, 2023
Liabilities:
Cross-currency swap derivative contracts$— $— $— $— 
Deferred compensation plans$— $18.0 $— $18.0 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2022:
Liabilities:
Deferred compensation plans$— $15.8 $— $15.8 
Contingent consideration$— $— $6.0 $6.0 
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
March 31, 2023December 31, 2022
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $6.0 $6.0 
Cross-currency swap derivative contracts$— $— $— $— 
Convertible senior notes due 2025$510.8 $1,033.5 $510.0 $873.0 
Long-term debt$873.8 $873.8 $870.7 $870.7